Considering the pivotal role of BET proteins in the regulation of the transcription of growth-promoting genes and cell cycle regulators, the phenotypic perturbations of BRDs variants may potentially lead to oncogene activation thus significantly affect the tumour development [4]. This evidence concerns the gene DNER and neoplasm.